5. Gong C, Shi S, Dong P, Kan B, Gou M, Wang X, Li X, Luo F, Zhao X, Wei Y, Qian Z.Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel.. Int J Pharm. 2009 Jan 5;365(1-2):89-99.
6. Lin Zhou, Jia Liu, Feng Luo. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006 February 28; 12(8):1175-1181(Corresponding author)
7. Ze Jun Lu, Qi Fang Song, Qi Song, Sa Sa Jiang, Wei Wang, Lan Tu Gou, Bin Kan, Gao Hua Zhang, Zhi Yong Qian, Li Juan Chen , Jin Liang Yang, Feng Luo, Yu Quan Wei. Identification of ATP synthase beta subunit (ATPB) on the cell surface as the non-small cell lung cancer (NSCLC) associated antigen. BMC Cancer. 2009 Jan 14;9(1):16.
8. Liu JY, Wei YQ, Yang L, Zhao X, Tian L, Hou JM, Niu T, Liu F, Jiang Y, Hu B, Wu Y, Su JM, Lou YY, He QM, Wen YJ, Yang JL, Kan B, Mao YQ, Luo F, Peng F. Immunotherapy www.lindalemus.com of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood. 2003 Sep 1;102(5):1815-23.
9. He QM, Wei YQ, Tian L, Zhao X, Su JM, Yang L, Lu Y, Kan B, Lou YY, Huang MJ, Xiao F, Liu JY, Hu B, Luo F, Jiang Y, Wen YJ, Deng HX, Li J, Niu T, Yang JL.  Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice.   J Biol Chem. 2003 Jun 13;278(24):21831-6.
10. Lu Y, Wei YQ, Tian L, Zhao X, Yang L, Hu B, Kan B, Wen YJ, Liu F, Deng HX, Li J, Mao YQ, Lei S, Huang MJ, Peng F, Jiang Y, Zhou H, Zhou LQ, Luo F.  Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor.  J Immunol. 2003 Mar 15;170(6):3162-70.
11. Li G, Tian L, Hou JM, Ding ZY, He QM, Feng P, Wen YJ, Xiao F, Yao B, Zhang R, Peng F, Jiang Y, Luo F, Zhao X, Zhang L, Zhou Q, Wei YQ.  Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors.  Clin Cancer Res. 2005 Jun 1;11(11):4217-24
12. Jiang Y, Wei YQ, Luo F, Zou LQ, Liu JY, Peng F, Huang MJ, He QM  Gemcitabine and cisplatin in advanced nasopharyngeal carcinoma: a pilot study.   Cancer Invest. 2005;23(2):123-8.
13. Peng F, Wei YQ, Tian L, Yang L, Zhao X, Lu Y, Mao YQ, Kan B, Lei S, Wang GS, Jiang Y, Wang QR, Luo F, Zou LQ, Liu JY. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand. J www.lindalemus.com Cancer Res Clin Oncol. 2002 Apr; 128(4):223-30.
14. Lou YY, Wei YQ, Yang L, Zhao X, Tian L, Lu Y, Wen YJ, Liu F, Huang MJ, Kang B, Xiao F, Su JM, He QM, Xie XJ, Mao YQ, Lei S, Liu JY, Lou F, Zhou LQ, Peng F, Jiang Y, Hu B. Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin beta3. Immunol Invest. 2002 Feb; 31(1):51-69.
15. Luo F, Wei YQ, Peng F. The treatment effects and mechanism of highly agglutinative staphylococci, local therapy in patients with superficial metastatic tumor. Chinese Journal of Cancer Research 2001; 2(3):232-3.
16. Wei YQ, Wang QR, Zhao X, Yang L, Tian L, Lu Y, Kang B, Lu CJ, Huang MJ, Lou YY, Xiao F, He QM, Shu JM, Xie XJ, Mao YQ, Lei S, Luo F, Zhou LQ, Liu CE, Zhou H, Jiang Y, Peng F, Yuan LP, Li Q, Wu Y, Liu JY. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nature Medicine. 2000 Oct; 6(10):1160-6.
17. Wei YQ, Huang MJ, Yang L, Zhao X, Tian L, Lu Y, Shu JM, Lu CJ, Niu T, Kang B, Mao YQ, Liu F, Wen YJ, Lei S, Luo F, Zhou LQ, Peng F, Jiang Y, Liu JY, Zhou H, Wang QR, He QM, Xiao F, Lou YY, Xie XJ, Li Q, Wu Y, Ding ZY, Hu B, Hu M, Zhang W. Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci U S A. 2001 Sep 25; 98(20):11545-50.
18. Yu-quan Wei, Xia,Zhao, Feng Luo,Song Luo,Li-qun Zoul. Induction of apoptosis by quercetin and its enhancemnt by heat treatment.          Radiotherapy and Oncology.1997;43:546.
联系方式:
电话： 028-85422683 　　　邮箱:luofeng@medmail.com.cn

上一页  [1] [2] [3]  下一页